Most colonic arteriovenous malformations, more commonly called angiodysplasias, develop because aging blood vessels in the colon wall gradually stretch and weaken until tiny abnormal connections form between arteries and veins. This degenerative process accounts for the vast majority of cases, though a smaller number trace back to inherited genetic mutations or congenital vascular defects present from birth. The picture is further complicated by molecular signals that promote abnormal vessel growth and by chronic diseases that accelerate the damage, making the full story more layered than a single cause.
How Aging Blood Vessels Create the Problem
The most widely accepted explanation centers on what happens to the veins buried in the colon wall over decades of use. The colon’s muscular layers contract repeatedly during normal bowel activity, and each contraction temporarily squeezes the small veins running through the submucosa, the tissue layer just beneath the inner lining. Over years, this chronic, low-grade obstruction causes those submucosal veins to gradually dilate and become tortuous. The backpressure then works its way upstream, widening the smaller venules and capillaries closer to the mucosal surface. Eventually the tiny precapillary sphincters that normally keep arterial blood from flowing directly into veins lose their ability to close properly, and small arteriovenous communications open up. That is the malformation itself: a short-circuit where blood bypasses the normal capillary bed and flows directly from artery to vein.
A landmark study examining right colons removed during cancer surgery in patients with no history of gastrointestinal bleeding found that these vascular ectasias were present in a meaningful portion of people over 60, whether or not they had ever bled. The researchers concluded that angiodysplasia is fundamentally a degenerative lesion of aging, not a rare anomaly, and that the dilated submucosal veins are the primary feature with the mucosal changes appearing secondarily.1Gastroenterology. On the Nature and Etiology of Vascular Ectasias of the Colon: Degenerative lesions of aging This means many people carry these lesions silently and never know it.
Why the Right Colon Gets Hit Hardest
Colonic angiodysplasias show a strong preference for the cecum and ascending colon, the right side of the large intestine. The explanation ties back to basic physics. The cecum has the widest diameter of any part of the colon, and according to the law of Laplace, the wall tension required to withstand a given internal pressure increases with vessel or tube diameter. That means the blood vessels in the cecal wall endure more mechanical stress during each muscular contraction than vessels in the narrower descending colon. Over a lifetime, that extra stress accelerates the stretching and dilation of submucosal veins in the right colon, making it the most common site for degenerative angiodysplasia.
That said, angiodysplasias can and do appear throughout the colon, including the descending and sigmoid segments. When lesions turn up in unusual locations, physicians sometimes look harder for alternative explanations like inherited conditions or portal hypertension rather than assuming the standard degenerative process alone.
The Role of Abnormal Blood Vessel Growth Signals
Aging and mechanical stress set the stage, but molecular signaling helps explain why certain vessel beds cross the line from slightly stretched to frankly malformed. Vascular endothelial growth factor, or VEGF, is a protein the body uses to stimulate new blood vessel formation. In angiodysplasia, VEGF appears to be part of the problem rather than the solution. Research has found that VEGF was strongly expressed in about three-quarters of patients with angiodysplasia lesions, far more than in tissue without lesions. Laboratory experiments in the same study showed that low-oxygen conditions ramped up VEGF production in vessel-lining cells, and that another growth factor called basic fibroblast growth factor further boosted both cell proliferation and VEGF expression.2PubMed. Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide
The implication is a feedback loop. As the colon’s vessel walls thin and stretch with age, local oxygen delivery becomes less efficient, creating pockets of mild hypoxia. That low-oxygen environment triggers VEGF release, which promotes further abnormal vessel growth and dilation, making the malformation worse. Several groups have proposed that this VEGF-driven angiogenesis is a key bridge between the initial mechanical insult and the fully formed arteriovenous malformation.3ScienceDirect / Journal of the Formosan Medical Association. Clinical characteristics and risk factors of active bleeding in colonic angiodysplasia among the Taiwanese Understanding this pathway has practical consequences for treatment, as several drugs now target VEGF directly.
Inflammation, Pericyte Loss, and the Aging Gut
A more recently explored piece of the puzzle involves the structural support cells that wrap around small blood vessels, called pericytes. Pericytes act like scaffolding, keeping capillaries stable and preventing them from becoming leaky or dilated. In the aging colon, low-grade chronic inflammation, sometimes called inflammaging, appears to strip away this scaffolding. Research in animal models has shown that as the colon ages, immune cells called macrophages infiltrate the tissue in greater numbers and release an inflammatory signal called TNF-alpha. This prompts the vessel-lining cells to overproduce a molecule called angiopoietin-2, which in turn disrupts the signaling that normally keeps pericytes attached to vessels. The result is pericyte loss, vascular instability, and leaky, malformed vessels.4Haematologica. von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy
This mechanism helps explain why angiodysplasia is so strongly linked to older age and why it tends to affect the gut specifically. The colon is constantly exposed to bacterial products and mild immune activation, even in healthy people, and that baseline inflammatory activity intensifies with age. Pericyte loss may represent one of the earliest structural changes that allows the degenerative cascade to take hold.
When the Cause Is Inherited
A small but clinically important subset of colonic arteriovenous malformations has a genetic origin. Hereditary hemorrhagic telangiectasia, commonly known as HHT or Osler-Weber-Rendu syndrome, is an inherited disorder in which abnormal blood vessels form throughout the body, including the gastrointestinal tract. HHT type 1 is caused by mutations in the ENG gene on chromosome 9, which encodes a protein called endoglin, while HHT type 2 results from mutations in the ACVRL1 gene on chromosome 12, which encodes activin receptor-like kinase 1. Together, mutations in these two genes account for most clinical cases.5Journal of Thrombosis and Haemostasis. Hereditary hemorrhagic telangiectasia: from molecular biology to patient care
Both endoglin and ALK1 are involved in the TGF-beta signaling pathway, which regulates how blood vessels grow, remodel, and maintain their structure. When either protein is defective, the normal checks on vessel formation break down, and the body produces fragile, thin-walled vessels that lack the smooth muscle support of normal arteries and veins. In the colon, these malformations can cause recurrent bleeding that is difficult to control. HHT-related lesions tend to show up earlier in life than degenerative angiodysplasia and often appear at multiple sites throughout the GI tract, not just in the right colon. If a younger patient presents with colonic AVMs, especially alongside nosebleeds or visible telangiectasias on the lips and fingertips, HHT should be considered.
Congenital Malformations That Persist from Birth
Separate from HHT, some colonic AVMs are truly congenital, meaning they formed during embryonic development when the primitive vascular network was being sorted into arteries and veins. During normal fetal development, temporary connections exist between the arterial and venous systems. These are supposed to close as dedicated artery and vein walls mature. Occasionally, some of those embryonic connections persist into adulthood. These congenital AVMs are classified as remnants of embryonic vasculature that never properly differentiated.6PubMed Central. Inferior mesenteric arteriovenous malformation extending to splenic flexure colonic wall presenting with massive lower gastrointestinal bleeding, a case report
Congenital colonic AVMs are far rarer than the acquired, degenerative type and can be dramatic when they finally cause symptoms. They sometimes involve larger feeding arteries and draining veins and can present with sudden, massive lower GI bleeding rather than the slow, occult blood loss typical of small angiodysplasias. Because they are structural from birth, they do not respond to the same medical therapies aimed at VEGF or inflammation and often require surgical resection or embolization.
Heart Disease, Kidney Disease, and Heyde Syndrome
Several chronic illnesses create conditions that either promote angiodysplasia formation or make existing lesions more likely to bleed. The most well-characterized of these is Heyde syndrome, a triad of aortic stenosis, gastrointestinal bleeding from angiodysplasia, and an acquired deficiency of certain blood-clotting factors. When blood is forced through a narrowed aortic valve at high speed, the shear stress physically shreds large von Willebrand factor multimers, the clotting proteins needed to seal damaged vessels. The result is a double hit: the patient has fragile, malformed vessels in the colon and simultaneously lacks the clotting machinery to stop them from bleeding.7PubMed Central. Heyde syndrome: gastrointestinal bleeding and aortic stenosis Replacing the aortic valve often resolves the bleeding, which is striking evidence for how tightly the heart and gut vasculature are linked in this condition.
Chronic kidney disease is another recognized contributor. Patients on long-term dialysis have higher rates of colonic angiodysplasia than the general population. Multiple factors seem to converge: uremic platelet dysfunction impairs clotting, frequent use of blood thinners and antiplatelet drugs adds risk, cardiovascular comorbidities are common in this group, and the aging process itself is accelerated in chronic kidney disease.8PubMed Central. Angiodysplasia in Renal Disease Patients: Analysis of Risk Factors and Approach to Manage Such Patients The precise mechanism by which kidney failure promotes the structural vessel changes is still debated, but the clinical association is consistent enough that GI bleeding in a dialysis patient should prompt a search for angiodysplasia.
What Makes Existing Lesions Bleed
Having a colonic AVM and bleeding from one are two different things. Many people carry these lesions for years without symptoms. The transition to active bleeding depends on a separate set of risk factors, and understanding them matters because they are often modifiable.
A multivariate analysis of patients with confirmed colonic angiodysplasia found that several factors independently raised the odds of active bleeding: advanced age, coexisting heart disease, use of anticoagulant drugs, having multiple lesions, and paradoxically, having small lesions of 5 mm or less. The small-lesion finding may reflect how easily tiny, thin-walled vessels rupture under even minor hemodynamic stress.9PubMed. Risk factors for active bleeding from colonic angiodysplasia confirmed by colonoscopic observation Another study focusing on elderly patients with active bleeding found that every patient in the series had chronic heart disease and was on anticoagulant or antiplatelet therapy, reinforcing the pattern that these medications uncover bleeding from lesions that might otherwise remain silent.10PubMed. Clinical features and endoscopic findings in patients with actively bleeding colonic angiodysplasia
This distinction between having the lesion and bleeding from it is clinically important. Many incidentally discovered angiodysplasias during routine colonoscopy are left alone if the patient has no bleeding history. But if someone on blood thinners starts having unexplained anemia or dark stools, angiodysplasia should be high on the list of suspects.
How Colonic AVMs Are Identified
Colonic angiodysplasias are usually found during colonoscopy, where they have a characteristic look that experienced endoscopists recognize. They typically appear as flat or slightly raised red lesions with a spider-like or radiating pattern of dilated capillaries. Their diameter generally ranges from about 5 mm up to around 10 or 12 mm, though some are barely visible to the naked eye.11PubMed Central. Colonoscopic and Clinical Features of Colonic Angiodysplasia: A Study in 54 Patients Some lesions have sharply defined borders while others blend into the surrounding mucosa, and they can be single or multiple, scattered or clustered.12PubMed Central. Diffuse telangiectasia of the colon
The very smallest lesions, sometimes called micro-angiodysplasias, pose a diagnostic challenge because they can be invisible during a standard colonoscopy unless the bowel preparation is excellent and the endoscopist is specifically looking for them. When colonoscopy is inconclusive in a patient with recurrent GI bleeding, CT angiography or tagged red blood cell scans can sometimes identify the source, especially during active bleeding episodes. For congenital AVMs involving larger vessels, conventional angiography remains valuable both for diagnosis and because it allows simultaneous embolization treatment.
Treatments That Target the Underlying Causes
Because the causes of colonic AVMs are varied, so are the treatment approaches. For a single or small number of lesions found during colonoscopy, endoscopic ablation using argon plasma coagulation is the most common first step. This cauterizes the abnormal vessels on the mucosal surface, though it does not address the deeper submucosal changes that gave rise to the lesion, which is why recurrence rates are not trivial.
For patients with recurrent or widespread angiodysplasia where endoscopic treatment is impractical, medical therapies aim at the molecular drivers. Octreotide, a synthetic hormone analog, works partly by reducing blood flow to the gut’s vascular bed and partly by modulating VEGF signaling.13Frontiers in Gastroenterology. Role of thalidomide in angiodysplasia-related gastrointestinal bleeding: a systematic review Thalidomide, once notorious for its teratogenic effects, has found a second life as an anti-angiogenic agent. It suppresses VEGF and other growth factors, directly counteracting the molecular feedback loop described earlier. Bevacizumab, a monoclonal antibody that blocks VEGF from binding to its receptors on blood vessel cells, represents a more targeted approach and is sometimes used as a last resort when other options fail.14Journal of Clinical and Experimental Gastroenterology. Thalidomide in gastrointestinal angiodysplasia: translating systematic evidence into clinical practice – Section: Bevacizumab: A Last-Resort Option
For Heyde syndrome, the most effective treatment is aortic valve replacement, which removes the mechanical cause of von Willebrand factor destruction and often stops the bleeding cycle entirely. For congenital AVMs with large feeding vessels, surgical resection of the affected bowel segment or interventional embolization through the blood supply is sometimes the only definitive option. The choice of treatment depends heavily on which underlying cause is driving the malformation, which is why understanding the mechanism in each individual patient matters more than applying a one-size-fits-all approach.
Why Some People Get Colonic AVMs and Others Do Not
Given that the degenerative process is nearly universal in people past middle age, the fact that only some develop clinically significant angiodysplasia raises a genuine puzzle. Part of the answer is likely that many people do have subclinical lesions and simply never know. But among those who do develop symptomatic AVMs, the combination of risk factors seems to matter more than any single cause. Someone with a genetically determined tendency toward leaky vessels, a sedentary lifestyle that promotes chronic low-grade inflammation, a heart valve that is beginning to stiffen, and a daily aspirin for cardiovascular prevention is stacking the deck in ways that someone with only one of those factors is not.
Research into the gut’s local inflammatory environment, the role of the microbiome in vascular health, and the genetics of vessel wall maintenance is still in early stages. The inflammaging pathway involving pericyte loss is particularly interesting because it suggests potential targets for prevention rather than just treatment. If the process of losing vascular scaffolding could be slowed, it might be possible to delay or prevent the formation of angiodysplasias in the first place. For now, that remains speculative, but it represents one of the more promising directions in a field that has relied on the same basic degenerative model for decades.